Mariner LLC Has $1.60 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Mariner LLC reduced its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 23.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,856 shares of the company's stock after selling 25,062 shares during the quarter. Mariner LLC owned 0.07% of Privia Health Group worth $1,600,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in PRVA. First Horizon Advisors Inc. grew its holdings in shares of Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after acquiring an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Privia Health Group by 7,833.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock worth $47,000 after acquiring an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. purchased a new stake in shares of Privia Health Group during the fourth quarter worth $51,000. Quadrant Capital Group LLC raised its holdings in shares of Privia Health Group by 11.8% during the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock worth $95,000 after acquiring an additional 511 shares in the last quarter. Finally, Nisa Investment Advisors LLC raised its holdings in shares of Privia Health Group by 185.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company's stock worth $98,000 after acquiring an additional 3,249 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CFO David Mountcastle sold 5,630 shares of Privia Health Group stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the transaction, the chief financial officer now owns 179,676 shares in the company, valued at $4,021,148.88. The trade was a 3.04 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 10.70% of the company's stock.

Privia Health Group Stock Up 0.3 %

PRVA stock traded up $0.07 during midday trading on Wednesday, reaching $23.48. The stock had a trading volume of 715,313 shares, compared to its average volume of 772,769. The business has a fifty day simple moving average of $23.55 and a two-hundred day simple moving average of $22.00. The firm has a market cap of $2.85 billion, a price-to-earnings ratio of 234.82, a PEG ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.04.

Wall Street Analyst Weigh In

Several analysts recently issued reports on PRVA shares. Barclays increased their price objective on Privia Health Group from $21.00 to $23.00 and gave the stock an "equal weight" rating in a report on Thursday, April 10th. JMP Securities restated a "market outperform" rating and set a $29.00 target price on shares of Privia Health Group in a report on Monday. Robert W. Baird raised their target price on Privia Health Group from $24.00 to $26.00 and gave the company an "outperform" rating in a report on Tuesday, April 15th. Needham & Company LLC reiterated a "buy" rating and issued a $30.00 price objective on shares of Privia Health Group in a research note on Thursday, April 10th. Finally, Truist Financial lifted their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research note on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Privia Health Group currently has an average rating of "Buy" and an average target price of $27.14.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.